US FDA approves Lilly and Incyte’s Olumiant for treating certain hospitalised patients with COVID-19 Read more
Lilly issues Complete Response Letter for Sintilimab in combination with Pemetrexed and Platinum chemotherapy for NSCLC treatment Read more
Eli Lilly announces Institute for Genetic Medicine and $700 million investment in Boston Seaport Site Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more
Experimental Lilly drug neutralises Omicron in lab; slightly higher risk of diabetes seen in kids after COVID Read more